Bone Mineral Density and Cystic Fibrosis: A Review
Authors
Abstract:
Cystic fibrosis (CF) is a common progressive genetic disorder among children which involves lungs, kidneys, intestine and liver. Apart from the significance of genetic factors, various environmental factors particularly bone mineral density are directly associated with CF. Remarkably, bone disease is appeared as a routine and common trait in long term CF survivors which implies that environmental parameters including calcium and vitamin D intake as well as drug inducement are the most important risk factors causing low bone mineral density. Conspicuously, absolute and notable treatment of cystic fibrosis associated to bone disorder must involve investigating the risk factors including the reduced intake of certain vitamins and minerals due to pancreatic inadequacy, modified hormone production, severe and chronic lung infection with increased ranges of bone function cytokines for a weak bone health situation. In this review, focus is on these considerable factors alongside the genetic factors in cystic fibrosis.
similar resources
Low Bone Mineral Density and Associated Factors in Patients with Cystic Fibrosis: A Cross-Sectional Study
Background: Failure to maintain bone mass density is a major complication in patients with cystic fibrosis (CF). This study was conducted to evaluate the prevalence of low bone mineral density (BMD) and also identifying associated risk factors in CF patients. Materials and Methods: Present study conducted on 59 CF patients aged 5-35 years referred to respiratory clinic of Masih Daneshvari Hospi...
full textNormal bone mineral density in cystic fibrosis.
BACKGROUND Osteoporosis has been reported as a complication of cystic fibrosis (CF). AIMS To measure bone mineral density (BMD) in non-acutely ill adults and bone mineral content (BMC) in children with CF. METHODS We analysed data from 28 adults and 13 children with CF. Corticosteroid use was minimal for the year prior to study in both groups. Dual x ray absorptiometry was used to measure t...
full textBone mineral density in adults with cystic fibrosis.
We have known of the increased risk of prematurely reduced bone mineral density (BMD) in children and young adults with cystic fibrosis since Mischler’s work of 20 years ago which documented significant deficiency in 44% of 27 patients. Bone metabolism, however, remained until recently an under-researched area of cystic fibrosis care, perhaps because patients were not expected to live long enou...
full textCorrelates of prepubertal bone mineral density in cystic fibrosis.
AIM To examine early factors in bone mineral accretion in cystic fibrosis (CF). METHODS In 22 prepubertal children with CF and mild lung disease, the relation between total body bone mineral density (BMD) and measures of body composition, biochemistry, lung function, and physical activity was studied. RESULTS There was a non-significant mild reduction in mean total body BMD. No relation was...
full textAlteration of bone mineral density in cystic fibrosis adults.
responses to these items, despite the inclusion of the “unable” option, suggests that the activities queried by these items may in fact be less relevant to the study population. In a recent publication by Barley and Jones,2 Rasch analysis was used to assess the measurement properties of the AQ20 over time. Item 3 was found to be unstable due an increase in “not applicable” responses related to ...
full textLow bone mineral density in adults with cystic fibrosis.
BACKGROUND Patients with cystic fibrosis have several risk factors for the development of low bone mineral density (BMD). To identify the prevalence and clinical correlates of low BMD in adult patients with cystic fibrosis, densitometry was performed in 151 patients (83 men) aged 15-52 years. METHODS BMD was measured in the lumbar spine (L1-4) using dual energy x ray absorptiometry (DXA) and ...
full textMy Resources
Journal title
volume 7 issue 7
pages 9701- 9710
publication date 2019-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023